| Name | Butamirate Citrate |
| Classes |
Respiratory Agent Cough Suppressant |
| Diseases |
Dry Cough Respiratory Disease |
Bangla
EnglishButamirate Citrate
Butamirate citrate belongs to a new class of cough suppressants that centrally through the receptors in the brainstem. It also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect.
Adult:
- 50 mg tablet: 2 or 3 tablets daily at intervals of 8 or 12 hours.
- As 7.5 mg/5 mL syrup: 22.5 mg (15 mL) up to 4 times daily. Max: 90 mg (60 mL) daily.
- Dosage recommendations may vary among countries or individual products (refer to specific product guidelines).
Child: Dosage recommendations may vary among countries or individual products (refer to specific product guidelines).
- Butamirate Citrate should not be used as a rescue medication for sudden worsening of respiratory symptoms.
- The medication should not be used in patients with a history of severe hypersensitivity to sympathomimetic amines.
- Patients should be advised to seek medical attention immediately if they experience any worsening of their respiratory symptoms while taking Butamirate Citrate.
Contraindication
Butamirate Citrate is contraindicated in patients with a known hypersensitivity to the active ingredient or any of the excipients in the product.
None known.
None known.